FrancophonIA/ELRC3.0 huggingface dataset:
English: Influenza-like illness includes events reported as acute phase reaction or symptoms, including myalgia, arthralgia, fever, chills, fatigue, nausea, loss of appetite, and bone pain.
Danish: Influenzalignende sygdom omfatter hændelser, der blev beskrevet som akut fasereaktion eller symptomer, inklusive myalgi, artralgi, feber, kulderystelser, træthed, kvalme, appetitløshed og knoglesmerter.
English: Ibandronic acid Accord belongs to a group of medicines called bisphosphonates.
Danish: Ibandronsyre Accord tilhører en medicingruppe, som kaldes bisphosphonater.
English: Elderly population (see section 4.2)
Danish: Ældre population (se pkt.
English: • if you are allergic to ibandronic acid or any of the other ingredients of this medicine (listed in section 6)
Danish: • hvis du er allergisk over for ibandronsyre eller et af de øvrige indholdsstoffer angivet i punkt 6
English: Chemical and physical in-use stability after dilution in 9 mg/ml (0.9 %) sodium chloride solution or 5% glucose solution has been demonstrated for 36 hours at 25°C and 2°C to 8°C.
Danish: Kemisk og fysisk stabilitet under anvendelse efter fortynding med 9 mg/ml (0,9%) natriumchloridinfusionsvæske eller 5% glucoseinfusionsvæske er blevet påvist for 36 timer ved 25°C og 2°C til 8°C.
English: In humans, the apparent terminal volume of distribution is at least 90 l and the amount of dose reaching the bone is estimated to be 40-50% of the circulating dose.
Danish: Hos mennesker er det tilsyneladende terminale fordelingsvolumen mindst 90 liter og det estimeres at 40-50% af den cirkulerende dosis bindes til knoglerne.
English: • a family history of osteoporosis
Danish: • osteoporose i familien
English: Chemical and physical in-use stability after dilution in 0.9 % sodium chloride or 5% glucose solution has been demonstrated for 36 hours at 25°C and 2°C to 8°C.
Danish: Der er påvist kemisk og fysisk stabilitet efter fortynding i 0,9 % natriumchlorid eller 5 % glucoseopløsning i 36 timer ved 25 °C og 2 °C til 8 °C.
English: Pre-filled syringes made of colourless glass, the grey plunger rubber stopper and tip cap, containing 3 ml of solution for injection.
Danish: Forfyldte injektionssprøjter lavet af farveløst glas med grå gummistempelstopper og gummiprop indeholdende 3 ml opløsning til injektion.
English: This is because Ibandronic acid Accord can affect the way some other medicines work.
Danish: Dette skyldes at Ibandronsyre Accord kan påvirke den måde anden medicin virker på, ligesom anden medicin kan påvirke den måde, hvorpå Ibandronsyre Accord virker.
English: It is supplied as packs containing 1, 5 or 10 vials with 6 ml of concentrate.
Danish: Det leveres i pakninger med 1, 5 eller 10 hætteglas med 6 ml opløsning.
English: Protein binding in human plasma is approximately 85 % - 87 % (determined in vitro at therapeutic ibandronic acid concentrations), and thus there is a low potential for interaction with other medicinal products due to displacement.
Danish: Proteinbindingen i humant plasma er ca. 85-87 % (bestemt in vitro ved terapeutiske ibandronsyrekoncentrationer).
English: Prior to treatment with Ibandronic acid Accord the patient should be adequately rehydrated with 9 mg/ml (0.9 %) sodium chloride.
Danish: Forud for behandling med Ibandronsyre Accord, bør patienten være tilfredsstillende hydreret med 9 mg/ml (0,9 %) natriumchlorid.
English: The most serious reported adverse reactions are anaphylactic reaction/shock, atypical fractures of the femur, osteonecrosis for the jaw and ocular inflammation (see paragraph “Description of selected adverse reactions” and section 4.4).
Danish: De mest alvorlige indberettede bivirkninger er anafylaktisk reaktion/shock, atypiske femurfrakturer, knoglenekrose i kæben og inflammation i øjet (se afsnittet ”Beskrivelse af udvalgte bivirkninger ” og pkt.
English: Clinical studies have not shown any evidence of deterioration in renal function with long term ibandronic acid therapy.
Danish: Kliniske studier har ikke vist tegn på forringelse af nyrefunktionen efter længerevarende ibandronsyrebehandling.
English: In humans, the efficacy of both daily and intermittent administration with a dose-free interval of 9 - 10 weeks of ibandronic acid was confirmed in a clinical trial (MF 4411), in which ibandronic acid demonstrated anti-fracture efficacy.
Danish: Hos mennesker blev effekten af både daglig og intermitterende administration af ibandronsyre med et dosisfrit interval på 9-10 uger bekræftet i et klinisk studie (MF 4411).
English: Overhydration should be avoided in patients at risk of cardiac failure.
Danish: Patienter med nedsat hjertefunktion Overhydrering skal undgås ved patienter med risiko for hjerteinsufficiens.
English: Ibandronic acid Accord 3 mg solution for injection in pre-filled syringe must not be mixed with calcium-containing solutions (such as Ringer-Lactate solution, calcium heparin) or other intravenously administered medicinal products.
Danish: Ibandronsyre Accord 3 mg injektionsvæske, opløsning, i fyldte injektionssprøjter må ikke blandes med opløsninger som indeholder calcium (som f.eks. Ringer-Laktat opløsning, calcium heparin) eller andre intravenøst administrerede lægemidler.
English: • pain or injury at the injection site
Danish: • smerte eller skade på injektionsstedet
English: There is no evidence that ibandronic acid is metabolised in animals or humans.
Danish: Der er ikke tegn på, at ibandronsyre metaboliseres i dyr eller mennesker.
English: Daily oral treatment with ibandronic acid 2.5 mg tablets resulted in progressive increases in BMD at vertebral and nonvertebral sites of the skeleton.
Danish: Daglig oral behandling med 2,5 mg ibandronsyre-tabletter resulterede i en tiltagende øgning af BMD både vertebralt og non-vertebralt.
English: Cases of osteonecrosis of the jaw have been reported, predominantly in cancer patients treated with medicinal products that inhibit bone resorption, such as ibandronic acid (see section 4.4.)
Danish: Tilfælde af osteonekrose i kæben er rapporteret, primært hos cancerpatienter behandlet med lægemidler, der hæmmer knogleresorptionen, såsom ibandronsyre (se pkt.
English: Metabolic interactions are not considered likely, since ibandronic acid does not inhibit the major human hepatic P450 isoenzymes and has been shown not to induce the hepatic cytochrome P450 system in rats (see section 5.2).
Danish: Metaboliske interaktioner anses ikke for sandsynlige, da ibandronsyre ikke hæmmer de primære humane hepatiske P450-isoenzymer og er vist ikke at inducere cytochrom P450-systemet hos rotter (se pkt.
English: BMD - mean change relative to baseline lumbar spine at year 3
Danish: BMD - gennemsnitlig ændring i forhold til baseline - lumbal columnaefter 3 år
English: North Harrow Middlesex HA1 4HF United Kingdom
Danish: North Harrow Middlesex HA1 4HF Storbritannien
English: Any unused solution for injection, syringe and injection needle should be disposed of in accordance with local requirements.
Danish: Ubrugt injektionsopløsning, injektionssprøjte og injektionskanyle skal bortskaffes i overensstemmelse med lokale krav.
English: Prevention of skeletal events in patients with breast cancer and bone metastases with ibandronic acid 6 mg administered intravenously was assessed in one randomized placebo controlled phase III trial with duration of 96 weeks.
Danish: Behandlingen med ibandronsyre 6 mg administreret intravenøst ved forebyggelse af knoglerelaterede hændelser hos patienter med brystkræft og knoglemetastaser blev vurderet i en randomiseret, placebokontrolleret fase III undersøgelse, som varede i 96 uger.
English: Relative risk reduction of clinical vertebral fracture
Danish: Relativ risikoreduktion af kliniske vertebrale frakturer
English: See also dose section above for patients with renal impairment.
Danish: Se også afsnittet ovenfor vedrørende dosering af patienter med nedsat nyrefunktion
English: The recommended dose of ibandronic acid is 3 mg, administered as an intravenous injection over 1530 seconds, every three months.
Danish: Den anbefalede dosis af ibandronsyre er 3 mg hver 3. måned, administreret som en intravenøs injektion over 15-30 sekunder.
English: Caution is to be taken in patients with known hypersensitivity to other bisphosphonates.
Danish: Patienter med kendt overfølsomhed over for andre bisphosphonater Der skal udvises forsigtighed hos patienter med kendt overfølsomhed over for andre bisphosphonater.
English: Renal clearance of ibandronic acid in patients with various degrees of renal impairment is linearly related to creatinine clearance (CLcr).
Danish: Den renale clearance for ibandronsyre hos patienter med forskellige grader af nedsat nyrefunktion er lineært relateret til kreatininclearance (CLcr).
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/
Danish: Yderligere information om dette lægemiddel er tilgængelig på Det Europæiske Lægemiddelagenturs hjemmeside: http://www.ema.europa.eu/
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 6.
Danish: INDHOLD ANGIVET SOM VÆGT, VOLUMEN ELLER ANTAL DOSER 6.
English: Ibandronic acid leads to progressive net gains in bone mass and a decreased incidence of fractures through the reduction of elevated bone turnover towards premenopausal levels in postmenopausal women.
Danish: Ibandronsyre medfører hos postmenopausale kvinder en tiltagende forøgelse af knoglemassen og en nedsat frakturhyppighed ved en reduktion af den øgede knogleomsætning henimod et præmenopausalt niveau.
English: Ibandronic acid is only for use in postmenopausal women and must not be taken by women of child bearing potential.
Danish: Ibandronsyre er kun til brug hos postmenopausale kvinder og må ikke anvendes af fertile kvinder.
English: Contact your doctor and dentist immediately if you experience any problems with your mouth or teeth such as loose teeth, pain or swelling, non-healing of sores or discharge, as these could be signs of osteonecrosis of the jaw.
Danish: Kontakt straks din læge og tandlæge, hvis du får problemer med din mund eller dine tænder, for eksempel løse tænder, smerter eller hævelse, manglende opheling af sår eller udflåd, da det kan være tegn på ONJ.
English: An expected decrease in bone turnover, normal quality of bone and absence of defects in mineralization were also seen after two years of treatment with ibandronic acid 3 mg injection.
Danish: Der blev også set et forventet fald i knogleomsætning, normal knoglekvalitet og fravær af mineraliseringsdefekt efter 2-års behandling med i.v.
English: Clinical studies in the prevention of skeletal events in patients with breast cancer and bone metastases
Danish: Kliniske studier ved forebyggelse af knoglerelaterede hændelser hos patienter med brystkræft og knoglemetastaser
English: After that, go back to getting the injections every 3 months from the date of the most recent injection.
Danish: Derefter skal du fortsætte med at få injektionerne hver 3. måned regnet fra datoen for den sidste injektion.
English: The proportion of patients who increased or maintained their BMD at one year at both lumbar spine and total hip was 76.2 % in the 3 mg injection every 3 months arm and 67.2 % in the 2.5 mg daily orally arm (p=0.007).
Danish: Efter et år var andelen af patienter, som øgede eller fastholdt deres BMD for både lumbal og hofte, 76,2 % i behandlingsarmen med 3 mg injektion hver 3. måned og 67,2 % i armen med 2,5 mg daglig oralt (p=0,007).
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 2 mg/2 ml
Danish: INDHOLDSMÆNGDE ANGIVET SOM VÆGT, VOLUMEN ELLER ANTAL DOSER 2 mg/ 2 ml
English: If you forget to use Ibandronic acid Accord
Danish: Hvis du har glemt at bruge Ibandronsyre Accord
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 6 mg/6 ml
Danish: INDHOLDSMÆNGDE ANGIVET SOM VÆGT, VOLUMEN ELLER ANTAL DOSER 6 mg/6 ml
English: METHOD AND ROUTE(S) OF ADMINISTRATION Read the package leaflet before use.
Danish: ANVENDELSESMÅDE OG ADMINISTRATIONSVEJ Læs indlægssedlen inden brug
English: Children and adolescents Ibandronic acid Accord should not be used in children and adolescents below the age of 18 years.
Danish: Børn og unge Ibandronsyre Accord bør ikke anvendes til børn og unge under 18 år.
English: Pharmacokinetics of ibandronic acid are similar in men and women.
Danish: Farmakokinetikken for ibandronsyre er ens hos mænd og kvinder.
English: If you are not sure, talk to your doctor or pharmacist before having Ibandronic acid Accord.
Danish: Hvis du er i tvivl, så kontakt lægen eller apotekspersonalet, før du får Ibandronsyre Accord.
English: There is no relevant use of ibandronic acid in children below 18 years, and ibandronic acid was not studied in this population (see section 5.1 and 5.2).
Danish: Anvendelse af ibandronsyre er ikke relevant hos børn under 18 år, og der er ingen erfaring med behandling af denne population (se pkt.
English: • persistent eye pain and inflammation (if prolonged)
Danish: • vedvarende smerte og en betændelse slignende reaktion (inflammation) i øjet (hvis langvarig).
English: Do not use this medicine after the expiry date which is stated on the carton and on the syringe after “EXP”.
Danish: Brug ikke lægemidlet efter den udløbsdato, som er angivet på den ydre pakning og på injektionssprøjten efter EXP. Udløbsdatoen er den sidste dag i den nævnte måned.
English: Ibandronic acid Accord 2 mg and 6 mg concentrate for solution for infusion (for oncology indications)
Danish: Ibandronsyre Accord 2 mg og 6 mg koncentrat til infusionsvæske, opløsning (til onkologiske indikationer)
English: No specific information is available on the treatment of overdosage with ibandronic acid injection.
Danish: Der er ingen tilgængelig specifik information vedrørende behandling af overdosering med ibandronsyre til injektion.
English: dosing regimen, there was no evidence for a direct foetal toxic or teratogenic effect of ibandronic acid in rats and rabbits.
Danish: I studier med daglig intravenøs administration fandtes der ikke tegn på direkte føtal toksisk eller teratogen effekt af ibandronsyre hos rotter og kaniner.
English: Ibandronic acid Accord contains sodium
Danish: Ibandronsyre Accord indeholder natrium
English: The safety of oral treatment with ibandronic acid 2.5 mg daily was evaluated in 1251 patients treated in 4 placebo-controlled clinical studies, with the large majority of patients coming from the pivotal three-year fracture study (MF 4411).
Danish: Sikkerheden af oral behandling med ibandronsyre 2,5mg daglig er undersøgt hos 1.251 patienter, som indgik i 4 placebo-kontrollerede kliniske studier.
English: For patients with breast cancer and bone metastases, Ibandronic acid Accord infusion should be administered every 3-4 weeks.
Danish: Til patienter med brystkræft og knoglemetastaser skal Ibandronsyre Accord infusionen gives hver 3.-4. uge.
English: Packs of 1 pre-filled syringe and 1 injection needle or 4 pre-filled syringes and 4 injection needles.
Danish: Pakninger indeholdende 1 forfyldt sprøjte og 1 injektionskanyle eller 4 forfyldte sprøjter og 4 injektionskanyler.
English: Based on knowledge of this class of compounds, intravenous overdosage may result in hypocalcaemia, hypophosphataemia, and hypomagnesaemia.
Danish: Baseret på erfaringer fra lignende præparater inden for samme klasse kan intravenøs overdosering forårsage hypokalcæmi, hypophosphatæmi og hypomagnesæmi.
English: There are no adequate data from the use of ibandronic acid in pregnant women.
Danish: Der findes ingen adækvate data om anvendelsen af ibandronsyre til gravide.
English: You may have early signs of severe jaw problems (necrosis
Danish: Du kan have tidlige tegn på alvorlige problemer med kæben (nekrose (dødt knoglevæv) i kæbeknoglen)
English: No dose adjustment is necessary for patients with mild or moderate renal impairment where serum creatinine is equal or below 200 μmol/l (2.3 mg/dl) or where creatinine clearance (measured or estimated) is equal or greater than 30 ml/min.
Danish: Dosisjustering er ikke nødvendig hos patienter med let eller moderat nyreinsufficiens, hvor serumkreatinin er lig med eller mindre end 200 μmol/l (2,3 mg/dl) eller hvor kreatininclearance (målt eller estimeret) er lig med eller over 30 ml/min.
English: Ibandronic acid concentrate for solution for infusion should be administered as an intravenous infusion over 2 hours.
Danish: Ibandronsyre koncentrat til infusionsvæske skal administreres som intravenøs infusion over 2 timer.
English: In studies with daily i.v.
Danish: Kun til i.v.
English: For the prevention of skeletal events in patients with breast cancer and bone metastases, the Ibandronic acid Accord infusion is repeated at 3-4 week intervals.
Danish: Ved forebyggelse af knoglerelaterede hændelser hos patienter med brystkræft og knoglemetastaser gentages Ibandronsyre Accord infusionen med 3-4 ugers intervaller.
English: Table 1: Adverse reactions occurring in postmenopausal women receiving ibandronic acid 3 mg injection every 3 months or ibandronic acid 2.5 mg daily in the phase III studies BM16550 and MF 4411, and in post-marketing experience.
Danish: Bivirkninger hos postmenopausale kvinder, som fik ibandronsyre 3mg som injektion hver 3. måned eller ibandronsyre 2,5mg daglig i fase III studierne BM16550 og MF4411, samt bivirkninger set efter markedsføring.
English: Based on the results of study BM 16550, ibandronic acid 3 mg intravenous injection, administered every 3 months is expected to be at least as effective in preventing fractures as the oral regimen of ibandronic acid 2.5 mg daily.
Danish: Baseret på resultaterne fra studie BM 16550 forventes intravenøs injektion med ibandronsyre 3 mg hver 3. måned at være mindst ligeså effektivt som ibandronsyre 2,5 mg oralt daglig med hensyn til at forebygge frakturer.
English: No dose adjustment is necessary for patients with mild or moderate renal impairment (CLcr equal or above 30 ml/min).
Danish: Dosisjustering er ikke nødvendig for patienter med mild eller moderat nyrefunktionsnedsættelse (CLcr ≥ 30 ml/min).
English: At two years, 80.1 % and 68.8 % of patients met this criterion in the 3 mg every 3 months injection arm and the 2.5 mg daily arm (p=0.001).
Danish: Efter to år opfyldte henholdsvis 80,1 % og 68,8 % af patienterne dette kriterium i behandlingsarmenene, som fik henholdsvis injektion med 3 mg hver 3. måned og 2,5 mg daglig (p=0,001).
English: The recommended dose for prevention of skeletal events in patients with breast cancer and bone metastases is 6 mg intravenous injection given every 3-4 weeks.
Danish: Den anbefalede dosis ved forebyggelse af knoglerelaterede hændelser hos patienter med brystkræft og knoglemetastaser er 6 mg intravenøs injektion hver 3.-4. uge.
English: Studies in rats have shown reproductive toxicity (see section 5.3).
Danish: Studier på rotter har vist reproduktionstoksisitet (se pkt.
English: Ibandronic acid 3 mg intravenous injection, administered every 3 months, was shown to be at least as effective as oral ibandronic acid 2.5 mg daily in a 2-year, randomised, double-blind, multicentre, noninferiority study (BM16550) of postmenopausal women (1386 women aged 55 - 80) with osteoporosis (lumbar spine BMD T-score below -2.5 SD at baseline).
Danish: I et 2-års, randomiseret, dobbeltblindet, non-inferiority, multicenterstudie (BM 16550) var intravenøs injektion af ibandronsyre 3mg hver 3. måned mindst ligeså effektivt som oral ibandronsyre 2,5 mg daglig hos postmenopausale kvinder (1.386 kvinder i alderen 55-80 år) med osteoporose (lumbal BMD T-score under - 2,5SD ved baseline).
English: All patients received 500 mg calcium and 400 IU vitamin D daily.
Danish: Alle patienter fik dagligt 500 mg calcium og 400 IE vitamin D. Effekten evalueredes hos 2.928 patienter.
English: Ibandronic acid Accord 3 mg solutionfor injection (for osteoporosos indications) Medicinal product subject to medical prescription.
Danish: Ibandronsyre Accord 3 mg injektionsvæske, opløsning (til osteoporose indikation) Lægemidlet er receptpligtigt.
English: Ibandronic acid Accord is available in packs of 1 pre-filled syringe and 1 injection needle or 4 pre-filled syringes and 4 injection needles.
Danish: Ibandronsyre Accord kan fås i pakninger indeholdende 1 fyldt injektionssprøjte og 1 injektionskanyle eller 4 fyldte injektionssprøjter og 4 injektionskanyler.
English: For patients with mild renal impairment (CLcr ≥50 and <80 ml/min) no dose adjustment is necessary.
Danish: Hos patienter med let nedsat nyrefunktion (CLcr ≥ 50 og < 80 ml/min) er justering af dosis ikke nødvendig.
English: • stomach pain (such as gastritis) or tummy pain, , indigestion, nausea, having diarrhoea (loose bowels) or constipation
Danish: • mavesmerter (såsom mavekatar), fordøjelsesbesvær, kvalme, diarré (løs mave) eller forstoppelse.
English: Where the medicinal product is administered into an existing intravenous infusion line, the infusate should be restricted to either isotonic saline or 50 mg/ml (5 %) glucose solution.
Danish: Hvis præparatet administreres i en eksisterende intravenøs infusionsslange, skal infusionsvæsken begrænses til enten isotonisk saltvand eller 50 mg/ml (5 %) glucoseopløsning.
English: For treatment of tumour induced hypercalcaemia, Ibandronic acid Accord concentrate for solution for infusion is generally given as a single infusion.
Danish: Til behandling af tumorinduceret hyperkalcæmi skal Ibandronsyre Accord koncentrat til infusionsvæske, opløsning generelt gives som en enkelt infusion.
English: Overdose No specific information is available on the treatment of overdosage with Ibandronic acid Accord.
Danish: Der foreligger ingen særlige informationer om behandlingen af overdosering med Ibandronsyre Accord.
English: Patients treated with ibandronic acid should be given the package leaflet and the patient reminder card. Posology
Danish: Patienter, der behandles med ibandronsyre, skal have udleveret indlægssedlen og patientkortet.
English: There is no evidence for any clinically relevant inter-ethnic differences between Asians and Caucasians in ibandronic acid disposition.
Danish: Der er ikke noget der tyder på en klinisk relevant inter-etnisk forskel i tilstedeværelsen af ibandronsyre mellem asiater og kaukasere.
English: For total hip BMD, 82.3 % of patients receiving 3 mg injection every 3 months were responders at one year, compared with 75.1 % of patients receiving 2.5 mg daily orally (p=0.02).
Danish: Med hensyn til hofte BMD var 82,3% af patienterne, som fik en 3 mg injektion hver 3. måned, respondenter efter et år sammenlignet med 75,1% af patienterne, som fik 2,5mg dagligt oralt (p=0,02).
English: This medicine contains less than 1 mmol sodium (23 mg) per dose (3 ml), i.e. ‘essentially sodiumfree'.
Danish: Dette lægemiddel indeholder mindre end 1 mmol (23 mg) natrium pr. dosis (3 ml), dvs. den er i det væsentlige natriumfri.
English: Talk to your doctor, pharmacist or nurse before receiving Ibandronic acid Accord:
Danish: Kontakt lægen, apotekspersonalet eller sundhedspersonalet, før du får Ibandronsyre Accord:
English: Do not use Ibandronic acid Accord
Danish: Brug ikke Ibandronsyre Accord
English: The safety and efficacy of ibandronic acid in children and adolescents below the age of 18 years have not been established.
Danish: Ibandronsyres sikkerhed og virkning hos børn og unge under 18 år er ikke klarlagt.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE PAKNING
English: Up to now there is no experience of acute poisoning with Ibandronic acid Accord concentrate for solution for infusion.
Danish: Indtil nu foreligger der ingen erfaringer med akut forgiftning med Ibandronsyre Accord koncentrat til infusionsvæske, opløsning.
English: Ibandronic acid Accord 3 mg solution for injection in pre-filled syringe like other bisphosphonates administered intravenously, may cause a transient decrease in serum calcium values.
Danish: Ibandronsyre Accord 3 mg injektionsvæske, opløsning, i fyldte injektionssprøjter kan, som andre intravenøst administrerede bisphosphonater, forårsage forbigående fald i værdierne for serum-calcium.
English: Ibandronic acid solution for injection must not be mixed with calcium-containing solutions or other intravenously administered medicinal products.
Danish: Ibandronsyre-injektionsvæske, opløsning må ikke blandes med calciumholdige opløsninger eller andre intravenøst administrerede lægemidler.